These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4170305)

  • 1. [Pelvic phlebography in the study of cancer of the prostate].
    Algranati R; Alberti C; Zingoni F
    Minerva Med; 1967 Nov; 58(95):4160-4. PubMed ID: 4170305
    [No Abstract]   [Full Text] [Related]  

  • 2. Case study: Case No. 3. Supraprostatic nodule of benign prostatic hypertrophy and prostate carcinoma stage C.
    Gilbert TJ
    Semin Ultrasound CT MR; 1988 Oct; 9(5):377-8. PubMed ID: 2483528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laparoscopic pelvic lymphadenectomy in patients with cancer of the bladder and prostate].
    Dudiev SM
    Urologiia; 2000; (5):52-4. PubMed ID: 11392228
    [No Abstract]   [Full Text] [Related]  

  • 4. [Magnetic resonance spectroscopy. A new technic for the study and the diagnosis of prostatic disease].
    García-Segura JM; Sánchez Chapado M
    Arch Esp Urol; 1995 Jun; 48(5):423-46. PubMed ID: 7543739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suprapubic echography in the diagnosis of benign hyperplasia and cancer of the prostate. A controlled study of 108 cases].
    Tramonti M; Parisi L; Giganti B; Lazzeri V; Bellesi P
    Radiol Med; 1982 Oct; 68(10):725-30. PubMed ID: 6185973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rectally palpable tumors in the pelvis: a difficult differential diagnosis].
    Kuntz RM; Mokry G; Schütz W
    Med Klin; 1981 Nov; 76(23):656-8. PubMed ID: 6171714
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left supraclavicular adenopathy as a presenting feature of occult prostatic adenocarcinoma].
    González Serrano M; del Villar Sordo V; Puras Tellaeche A; Sanz Millán M
    Med Clin (Barc); 1989 Mar; 92(11):439. PubMed ID: 2725103
    [No Abstract]   [Full Text] [Related]  

  • 11. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated prostate cancer recurrence presenting as pelvic mass nine years after radical retropubic prostatectomy.
    Metzdorf MM; Schmidt JD
    Urology; 2007 Nov; 70(5):1007.e17-8. PubMed ID: 18068468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the prostate with metastases to the lungs].
    Traczyk K; Ponahajba A; Radzikowska E; Figura-Chojak E
    Pneumonol Pol; 1986 May; 54(5):196-204. PubMed ID: 3737439
    [No Abstract]   [Full Text] [Related]  

  • 15. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate].
    Hayakawa T; Mitsuya H; Kojima M; Hayase Y
    Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR scanning of the pelvis: initial experience with a 0.3 T system.
    Bryan PJ; Butler HE; LiPuma JP; Haaga JR; El Yousef SJ; Resnick MI; Cohen AM; Malviya VK; Nelson AD; Clampitt M
    AJR Am J Roentgenol; 1983 Dec; 141(6):1111-8. PubMed ID: 6196962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphography and phlebography in lymphatic metastases of prostatic cancer].
    Rosenbaum S; Galesanu MR; Gradinaru I; Ionescu I; Paulian D
    J Urol Nephrol (Paris); 1971 Mar; 77(3):235-40. PubMed ID: 5577225
    [No Abstract]   [Full Text] [Related]  

  • 20. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
    Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
    BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.